Photoresponsive Ferrocene‐ Augmented Iridium Polypyridyl Complex as an Oxidase Mimic for Selective Glutathione Sensing: Implications for Cancer Diagnostics and Therapy
Small · 2025
DOI: 10.1002/smll.202501627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Diksha J Baruah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Materials Sciences Group, Coal, Energy and Materials Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, I…. Hauptthemen laut MEDLINE: Iridium, Ferrous Compounds, Glutathione, Neoplasms. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Life Sciences Research Board.
Abstract (Originalsprache)
The enzyme‐mimic activity of a well‐defined structurally characterized organometallic complex, [Ir(ppy)₂(fcbpy)]PF₆( 1 ; ppy = 2‐phenylpyridine; fcbpy = 4‐ferrocenyl‐2,2′‐bipyridine), a bimetallic iridium‐polypyridyl complex is investigated under light irradiation for the first time. This complex exhibits an extended excited‐state lifetime of 592 ns due to bimetallic synergy, and possess oxidase‐mimic activity in the presence of light. Leveraging this light‐activated oxidase‐mimic activity, a simple colorimetric assay is developed that successfully differentiates cancerous cells from normal cells, based on elevated glutathione (GSH) levels. Moreover, in cell viability studies, treatment with 1.25 mg L −1 of [Ir(ppy)₂(fcbpy)]PF₆ resulted in only 32.25% viability in a cancer cell line (A549) compared to the untreated control, highlighting its potent anticancer potential. Importantly, noncancerous cells (BEAS‐2B) maintain ≈72% viability at up to 10 mg L −1 of catalyst concentration, indicating selective cytotoxicity toward cancer cells. This study establishes [Ir(ppy)₂(fcbpy)]PF₆ as a promising candidate for both diagnostic and therapeutic applications in cancer, introducing a novel class of organometallic complexes with significant potential in bioassay development and targeted cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Materials Sciences Group, Coal, Energy and Materials Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India.
- Academy of Scientific and Innovative Research, Ghaziabad, 201002, India.
- Centre for Infectious Diseases, Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India.
ORCID-Profile: Biswajit Saha
Förderung
- Life Sciences Research Board
Zitieren
APA
Baruah, D. J., Saikia, A., Barman, H., Manna, P., Saha, B., & Das, M. R. (2025). Photoresponsive Ferrocene‐ Augmented Iridium Polypyridyl Complex as an Oxidase Mimic for Selective Glutathione Sensing: Implications for Cancer Diagnostics and Therapy. Small. https://doi.org/10.1002/smll.202501627
Vancouver
Baruah DJ, Saikia A, Barman H, Manna P, Saha B, Das MR. Photoresponsive Ferrocene‐ Augmented Iridium Polypyridyl Complex as an Oxidase Mimic for Selective Glutathione Sensing: Implications for Cancer Diagnostics and Therapy. Small. 2025. doi:10.1002/smll.202501627
BibTeX
@article{Baruah2025,
author = {Baruah, Diksha J and Saikia, Ankumoni and Barman, Hiranmoy and Manna, Prasenjit and Saha, Biswajit and Das, Manash R},
title = {Photoresponsive Ferrocene‐ Augmented Iridium Polypyridyl Complex as an Oxidase Mimic for Selective Glutathione Sensing: Implications for Cancer Diagnostics and Therapy},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202501627}
}
EUVIMED